Table 3

Demographic and clinical characteristics of rheumatoid arthritis and gout synovial tissue (quantitative polymerase chain reaction)
Rheumatoid arthritis (n= 22) Gout (n= 12)
Age (years) 60 ± 8 62 ± 14
Sex, female/male 13/9 2/10
Disease duration (years) 13 ± 14 2.3 ± 1.7
Swollen joint count 7 ± 5 2 ± 3
C-reactive protein (mg/l) 20 ± 26 36 ± 31
Disease Activity Score in 28 joints 5.0 ± 1.2 nd
Erythrocyte sedimentation rate (mm/hour) 38 ± 31 35 ± 20
IgM-RF (kU/l) 464 ± 1366 nd
Anti-CCP (kAU/ml) 2197 ± 3475 nd
Number taking NSAIDS (positive/negative) 12/22 4/12
Number taking corticosteroids (positive/negative) 9/22 1/12
Number taking DMARDs (positive/negative) 12/22 0/12
Number taking anti-tumor necrosis factor (positive/negative) 6/22 0/12

Data presented as mean ± standard deviation or number. anti-CCP, anti-cyclic citrullinated protein; DMARD, disease-modifying anti-rheumatic drug; IgM-RF, IgM rheumatoid factor; nd, not determined; NSAID, nonsteroidal anti-inflammatory drug.

Ramos et al.

Ramos et al. Arthritis Research & Therapy 2013 15:R209   doi:10.1186/ar4403

Open Data